Sumit Mohan

Professor of Medicine & Epidemiology
Columbia University
Sumit Mohan

Brief Bio

Dr. Sumit Mohan is an associate professor of medicine & epidemiology at Columbia University, the director of clinical research in the Division of Nephrology and the director of quality and outcomes research for the transplant initiative at New York Presbyterian Hospital.

Dr. Mohan’s clinical and research career has been focused on improving access to care and outcomes for patients with kidney disease – especially those with end stage kidney disease and kidney transplantation. His research funding has come from the National Institutes of Health, National Science Foundation and the American Society of Transplantation among others.

Dr. Mohan’s research findings have directly informed public policy at the federal level related to patients with kidney disease including access to outpatient dialysis for acute kidney injury, elimination of early outcomes as a regulatory measure for transplant center recertification as well as the ongoing efforts to lower the discard of deceased donor kidneys in the United States. His work on the inappropriate discard of deceased donor kidneys has helped bring significant attention to this problem nationally. He serves on multiple committees for UNOS, SRTR, ASN and NKF among others. In addition, he has contributed to several Technical Expert Panels (TEPs) for the Center for Medicare and Medicaid services (CMS) and has been invited to present his research to the National Academy of Science, Engineering and Medicine.

Alliance Presentations

Adult And Child Holding Kidney Shaped Paper On Textured Blue Bac

Expanding Kidney Transplantation – The Need to Improve Organ Utilization

Thursday, November 10, 2022, at 2:00pm

The Alliance Conversation Series brings you cost-free, fast-paced collaborative opportunities that highlight successful donation and transplantation practices across the country. Through shared insight, multidisciplinary experts identify solutions to critical challenges affecting the community of practice and actively share them for open discussion and broader knowledge of effective practices.

The Alliance is not an advocacy organization and always intends to maintain an objective and unbiased perspective.

Sessions are designed to be approximately 30-45 minutes in length and encourage real-time feedback and participation from viewers.

Overview: Kidney transplantation is the ideal treatment for patients with end stage kidney disease. Deceased donor kidneys are a scarce and valuable resource that we have to use optimally in order to benefit the maximum number of patients possible. We will discuss the challenge of kidney discards, the evaluation of kidneys during the allocation process and the opportunities that exist to lower the discard rate.

Lifelong Networks

Our partners are the heart and soul of our organization. For more than 15 years, they have played a vital role providing quality education and programs to advance a shared mission.